Search filters

List of works by Hans-Jürgen Stellbrink

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study

scientific article published on 31 July 2013

Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

scientific article

Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients

scientific article published on March 2014

Antiviral drugs in the treatment of AIDS: what is in the pipeline ?

scientific article

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort ⬇️

scientific article published on September 9, 2011

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inf

scientific article published on 31 August 2017

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study

scientific article published on October 2010

Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma

scientific article

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

scientific article published in September 2003

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

scientific article published on July 2013

Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome

scientific article published on 19 October 2015

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

scientific article

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).

scientific article

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

scientific article published in May 2003

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany

scientific article

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection ⬇️

scientific article published on June 15, 2010

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany

scientific article

German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment

scientific article

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

scientific article published on 17 September 2016

HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans

scientific article

HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008

scientific article

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure ⬇️

scientific article published on August 1, 2012

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

scientific article

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study

scientific article published on October 2016

Morbidity in older HIV-infected patients: impact of long-term antiretroviral use.

scientific article published on April 2014

Mycotic brain abscess caused by opportunistic reptile pathogen

scientific article published on February 2005

Novel compounds for the treatment of HIV type-1 infection

scientific article published on January 2009

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

scientific article

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

scientific article published on 5 February 2016

Ongoing epidemic of lymphogranuloma venereum in HIV-positive men who have sex with men: how symptoms should guide treatment

scientific article

Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany

scientific article published on 12 July 2010

Postexposure prophylaxis in daily clinical practice

scientific article published on 31 March 2015

Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review

scientific article

Raltegravir in the management of HIV-infected patients.

scientific article published on 06 February 2009

Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma

scientific article published on July 2003

Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study

scientific article

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

scientific article

Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients

scientific article

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

scientific article published on 2 November 2017

Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b,

scientific article published on March 2017

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

scientific article published on August 2007

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

scientific article

Treatment of HIV-infected patients: metabolism, bone, cardiovascular - what is part of routine care?

scientific article published on June 2017

Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C ⬇️

scientific article published on November 13, 2013

Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32

scientific article published on May 2015

Paulina is supported by:

About Paulina

Help